Renal disease drugs

Use with caution in severe renal disease. In patients with renal disease, thiazides may precipitate azotemia. Cumulative effects of the drug may develop in

Accelerating Drug Development for Chronic Kidney Disease and End-Stage Renal Disease drugs for kidney-related diseases. Discussion

83 References Drug dosing adjustments in patients with chronic kidney disease. Drug Therapy in Patients With Chronic Renal Failure Drug prescribing in renal

Renal transplant recipients are at an increased risk of infection, cardiovascular disease, drug interactions, various degrees of renal impairment and

The Renal Drug Database is an easy-to-use digital tool for pharmacists, clinicians, and other healthcare professionals prescribing for patients with renal disease and who receive renal replacement therapy. Written by clinical renal pharmacists, The Renal Drug Database provides dose adjustment suggestions based on disease characteristics.

even in the absence of atherosclerotic renal artery stenosis, antihypertensive drugs can kidney disease, affecting autoregulation of renal

The Chronic Renal Disease Program (CRDP) provides life-saving care and treatment for adults with end-stage renal disease. End-stage renal disease is a

Renal disease alters the effects of many drugs, particularly when active drug moieties are renally cleared. Drug doses should usually be reduced in renal disease in proportion to the predicted reduction in clearance of the active drug moiety. Patient factors to consider in adjusting drug doses include the degree of renal impairment and patient

Renal transplant recipients are at an increased risk of infection, cardiovascular disease, drug interactions, various degrees of renal impairment and